1. P230 Once-daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use. (10th November 2014) Authors: Dahl, R; Doherty, DE; Corren, J; Karpel, J; Kerstjens, HAM; Engel, M; Moroni-Zentgraf, P; Schmidt, H; Hashimoto, S Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P44 Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients regardless of prior exacerbation history in the phase 3 LIBERTY ASTHMA QUEST study. (December 2018) Authors: Pavord, I; Ford, LB; Corren, J; Kuna, P; Dong, Q; Staudinger, H; Maroni, J; Rowe, P; Rout, R; Amin, N; Akinlade, B; Graham, NMH; Teper, A Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S127 Relation between change in type 2 biomarker levels and efficacy outcomes in patients with asthma treated with dupilumab. (11th November 2022) Authors: Pavord, ID; Deniz, Y; Casale, T; Corren, J; FitzGerald, JM; Altincatal, A; Gall, R; Pandit-Abid, N; Radwan, A; Jacob-Nara, JA; Rowe, PJ; Busse, WW Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗